In addition, SIRT6 and TRF2 expression levels were inversely correlated in a cohort of CRC patients, suggesting a regulatory mechanism whereby SIRT6 induces degradation of TRF2, which is overexpressed during oncogenesis. This evidence concerns the gene SIRT6 and colorectal carcinoma.